Pharmacotherapy for Aphasia

Daniel Adolfo Llano, Steven L. Small

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

There are no currently approved drug therapies to assist in the recovery from aphasia. However, there is suggestive evidence from the animal literature that behavioral training, coupled with pharmacotherapy, can enhance recovery from motor stroke. Most of the pharmacologic interventions used in these studies involved sympathomimetic drugs, although other mechanisms were used as well, such enhancement in cholinergic signaling. A number of studies have been performed using human patients with aphasia. These studies are also suggestive of enhancement in recovery when sympathomimetic drugs are used in conjunction with speech and language therapy. There are also data to support cholinesterase inhibitors memantine and piracetam. In addition, other drugs, such as barbiturates, antipsychotics, and anticonvulsants, may slow recovery. Although more work is needed, these studies, which are critically reviewed herein, suggest that thoughtful use of pharmacologic agents in conjunction with speech and language therapy can enhance recovery from aphasic stroke.

Original languageEnglish (US)
Title of host publicationNeurobiology of Language
PublisherElsevier Inc.
Pages1067-1083
Number of pages17
ISBN (Electronic)9780124078628
ISBN (Print)9780124077942
DOIs
StatePublished - Jan 1 2015

Fingerprint

Language Therapy
Speech Therapy
Sympathomimetics
Aphasia
Stroke
Piracetam
Memantine
Drug Therapy
Barbiturates
Cholinesterase Inhibitors
Anticonvulsants
Cholinergic Agents
Antipsychotic Agents
Pharmaceutical Preparations

Keywords

  • Aphasia
  • Donepezil
  • Memantine
  • Rehabilitation
  • Stroke
  • Sympathomimetic

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Llano, D. A., & Small, S. L. (2015). Pharmacotherapy for Aphasia. In Neurobiology of Language (pp. 1067-1083). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-407794-2.00085-7

Pharmacotherapy for Aphasia. / Llano, Daniel Adolfo; Small, Steven L.

Neurobiology of Language. Elsevier Inc., 2015. p. 1067-1083.

Research output: Chapter in Book/Report/Conference proceedingChapter

Llano, DA & Small, SL 2015, Pharmacotherapy for Aphasia. in Neurobiology of Language. Elsevier Inc., pp. 1067-1083. https://doi.org/10.1016/B978-0-12-407794-2.00085-7
Llano DA, Small SL. Pharmacotherapy for Aphasia. In Neurobiology of Language. Elsevier Inc. 2015. p. 1067-1083 https://doi.org/10.1016/B978-0-12-407794-2.00085-7
Llano, Daniel Adolfo ; Small, Steven L. / Pharmacotherapy for Aphasia. Neurobiology of Language. Elsevier Inc., 2015. pp. 1067-1083
@inbook{56d45b29c16246aabca12d29177bd5a4,
title = "Pharmacotherapy for Aphasia",
abstract = "There are no currently approved drug therapies to assist in the recovery from aphasia. However, there is suggestive evidence from the animal literature that behavioral training, coupled with pharmacotherapy, can enhance recovery from motor stroke. Most of the pharmacologic interventions used in these studies involved sympathomimetic drugs, although other mechanisms were used as well, such enhancement in cholinergic signaling. A number of studies have been performed using human patients with aphasia. These studies are also suggestive of enhancement in recovery when sympathomimetic drugs are used in conjunction with speech and language therapy. There are also data to support cholinesterase inhibitors memantine and piracetam. In addition, other drugs, such as barbiturates, antipsychotics, and anticonvulsants, may slow recovery. Although more work is needed, these studies, which are critically reviewed herein, suggest that thoughtful use of pharmacologic agents in conjunction with speech and language therapy can enhance recovery from aphasic stroke.",
keywords = "Aphasia, Donepezil, Memantine, Rehabilitation, Stroke, Sympathomimetic",
author = "Llano, {Daniel Adolfo} and Small, {Steven L.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-407794-2.00085-7",
language = "English (US)",
isbn = "9780124077942",
pages = "1067--1083",
booktitle = "Neurobiology of Language",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Pharmacotherapy for Aphasia

AU - Llano, Daniel Adolfo

AU - Small, Steven L.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - There are no currently approved drug therapies to assist in the recovery from aphasia. However, there is suggestive evidence from the animal literature that behavioral training, coupled with pharmacotherapy, can enhance recovery from motor stroke. Most of the pharmacologic interventions used in these studies involved sympathomimetic drugs, although other mechanisms were used as well, such enhancement in cholinergic signaling. A number of studies have been performed using human patients with aphasia. These studies are also suggestive of enhancement in recovery when sympathomimetic drugs are used in conjunction with speech and language therapy. There are also data to support cholinesterase inhibitors memantine and piracetam. In addition, other drugs, such as barbiturates, antipsychotics, and anticonvulsants, may slow recovery. Although more work is needed, these studies, which are critically reviewed herein, suggest that thoughtful use of pharmacologic agents in conjunction with speech and language therapy can enhance recovery from aphasic stroke.

AB - There are no currently approved drug therapies to assist in the recovery from aphasia. However, there is suggestive evidence from the animal literature that behavioral training, coupled with pharmacotherapy, can enhance recovery from motor stroke. Most of the pharmacologic interventions used in these studies involved sympathomimetic drugs, although other mechanisms were used as well, such enhancement in cholinergic signaling. A number of studies have been performed using human patients with aphasia. These studies are also suggestive of enhancement in recovery when sympathomimetic drugs are used in conjunction with speech and language therapy. There are also data to support cholinesterase inhibitors memantine and piracetam. In addition, other drugs, such as barbiturates, antipsychotics, and anticonvulsants, may slow recovery. Although more work is needed, these studies, which are critically reviewed herein, suggest that thoughtful use of pharmacologic agents in conjunction with speech and language therapy can enhance recovery from aphasic stroke.

KW - Aphasia

KW - Donepezil

KW - Memantine

KW - Rehabilitation

KW - Stroke

KW - Sympathomimetic

UR - http://www.scopus.com/inward/record.url?scp=85021674373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021674373&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-407794-2.00085-7

DO - 10.1016/B978-0-12-407794-2.00085-7

M3 - Chapter

AN - SCOPUS:85021674373

SN - 9780124077942

SP - 1067

EP - 1083

BT - Neurobiology of Language

PB - Elsevier Inc.

ER -